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DISCUSSION
Oishi and co-workers present an interesting case of an intrahepatic arterioportal
fistula (APF) secondary to blunt abdominal trauma. This is a particularly educa-
tional case because the patient developed most of the potential complications of an
APF, notably portal hypertension with both bleeding varices and ascites, conges-
tive heart failure secondary to a hyperdynamic state, and a hepatic artery aneur-
ysm.
Although this fistula was secondary to abdominal trauma, most APFs are
secondary to percutaneous liver biopsy performed in patients with liver disease.
Most are asymptomatic and first detected when evaluating a variceal bleeder with
ultrasound or angiography. Since many of these individuals have coexisting cirrho-
sis, which was the reason for performance of the liver biopsy, it is often difficult to
determine whether the APF significantly contributes to the portal hypertension and
whether subsequent variceal hemorrhage could be prevented by treatment of the
APF alone. In our limited experience, we have seen two patients with cirrhosis who
continued to bleed from varices despite successful embolization of an APF. Both of
these individuals underwent chronic sclerotherapy which prevented rebleeding in
one, but the other patient failed sclerotherapy and eventually required portal
decompression. A selective shunt (distal splenorenal shunt) was chosen for that
patient because the prior embolization had interrupted a fraction of the hepatic
arterial blood supply. We thought it essential to preserve portal flow to avoid
infarction of hepatic parenchyma. Because of this potential problem, it is probably
preferable to ignore incidentally discovered APFs in variceal bleeders with cirrhosis
unless the APF is very large.
Although hepatic arterial embolization by interventional radiologic techniques is
probably the most common approach in treating symptomatic APFs, the patient
described by Oishi and co-authors required open surgery because of the size of the
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APF and the presence of a large hepatic artery aneurysm which also required
attention. The authors’ approach, which consisted of right hepatic lobectomy,
resection of the hepatic artery aneurysm and arterial revascularization of the left
hepatic lobe, was both innovative and successful in relieving portal hypertension
and the systemic hyperdynamic state.